LENZ Therapeutics, Inc.LENZNASDAQ
Loading
Gross Profit Over TimeExpanding
Percentile Rank100
3Y CAGR+7.3%
Studio
Year-over-Year Change

Revenue minus cost of goods sold

3Y CAGR
+7.3%/yr
Annual compound
Percentile
P100
Near historical high
vs 3Y Ago
1.2x
Modest growth
Streak
1 yr
Consecutive growthExpanding
PeriodValueYoY Change
TTM$18.55M+32074.1%
2024$-58000.00-
2023$0.00-100.0%
2022$15.00M+2143.6%
2021$-734000.00-506.6%
2020$-121000.00-
2019$0.00-